VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2025 Earnings Call Transcript November 10, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Vistagen Therapeutics Fiscal Year 2025 ...

As it happened, the day after Trump’s victory, was also the day of the “ Great Gold Puke “, as The Market Ear put it: ….must ...

In the wake of recent political shifts and economic policy changes, global markets have shown a mixed performance with U.S. stocks rallying on growth and tax hopes, while European markets face ...

In the wake of recent global market developments, U.S. stocks have experienced a rally driven by growth and tax optimism following the election, with small-cap indices like the Russell 2000 showing ...

Here we highlight a subset of our preferred stocks from the screener. Overview: Shenzhen Yanmade Technology Inc. focuses on the research, design, production, and sale of automated and intelligent test ...

The recent U.S. election results have sparked optimism in the markets, with major indices like the S&P 500 and Russell 2000 experiencing significant gains driven by expectations of economic growth and ...

Upon a potential return to the White House, Donald Trump has outlined a series of immediate actions for his first day and second term. These include dismissing legal cases against him, enacting ...

In recent years, non-alcoholic fatty liver disease (NAFLD) has developed rapidly worldwide and has become the main cause of chronic liver disease. With the increase in prevalence, the incidence of ...